Nanotechnology-enabled targeted delivery of incretin therapies for the treatment of obesity and metabolic disorders

Obesity Medicine · Published 2026-05-01 · DOI 10.1016/j.obmed.2026.100712

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.obmed.2026.100712

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Related articles